Skip to content

Uterine vacuum tamponade for treatment of postpartum haemorrhage: a randomized study

Uterine vacuum tamponade for treatment of postpartum haemorrhage: a randomized study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR201907769424884
Enrollment
84
Registered
2019-07-01
Start date
2019-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum haemorrhage

Interventions

Suction tube uterine tamponade
Standard care

Sponsors

University of the Witwatersrand
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women 18 years old or more with PPH thought to be arising from the uterine cavity; condition not imminently life-threatening; no serious medical conditions. Other possible causes of haemorrhage such as cervical or vaginal tears will be excluded by inspection according to local care protocols prior to randomization

Exclusion criteria

Exclusion criteria: Absence of inclusion criteria

Design outcomes

Primary

MeasureTime frame
Measured blood loss within 60 minutes after enrollment >median for the control group (lognormal distribution comparison), or operative procedures (eg laparotomy, hysterectomy) or death

Secondary

MeasureTime frame
Mean blood loss within 60 minutes after enrollment.;Blood loss within 60 minutes after enrollment >500ml (lognormal distribution comparison) or operative procedures (eg laparotomy, hysterectomy) or death;Blood pressure, pulse and shock index 10 minutes after enrolment;Change in Haemoglobin levels pre- delivery to post delivery;Blood transfusion or death;ICU admission or death

Countries

Colombia, South Africa

Contacts

Public ContactJustus Hofmeyr

Director ECRU

justhof@gmail.com+27832809402

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026